What Happened
Biotechnology Rivalry With China Threatens US Medical Independence
The US is facing a national security question as its medicine becomes increasingly dependent on foreign-sourced active ingredients and China gains ground in biotechnology innovation. A recent literature review by Start Grow Reemain highlights the decline of American biopharmaceutical discovery capacity and the rise of China as a source of new medicine innovation. The US still holds advantages in university research and private risk capital, but its lead is under threat. The American Biosecurity Initiative argues that reclaiming the lead requires building American strength at home and extending it through allies, as reported by the Financial Times.